Clinical effectiveness and cost-effectiveness of Helicobacter pylori testing and treatment in patients receiving long-term ulcer prophylaxis

Am J Health Syst Pharm. 2004 Mar 15;61(6):608-12. doi: 10.1093/ajhp/61.6.608.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / economics
  • Anti-Bacterial Agents / therapeutic use
  • Anti-Ulcer Agents / economics
  • Anti-Ulcer Agents / therapeutic use
  • Cost-Benefit Analysis
  • Helicobacter Infections / complications
  • Helicobacter Infections / diagnosis*
  • Helicobacter Infections / drug therapy*
  • Helicobacter pylori / isolation & purification*
  • Humans
  • Mass Screening / economics*
  • Peptic Ulcer / microbiology
  • Peptic Ulcer / prevention & control*
  • Premedication
  • Treatment Outcome
  • United States
  • Veterans

Substances

  • Anti-Bacterial Agents
  • Anti-Ulcer Agents